Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More
Our People
Take a look into our corporate culture and view our open roles.
Join the Team
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us

Pharma advertising tax deductions are targeted by Congress again

The news: A bipartisan group of lawmakers introduced legislation to eliminate advertising tax deductions for pharma companies. Led by House Rep. Greg Murphy (R-NC), who’s also a physician, the “No Handouts for Drug Advertisements Act” would end tax write-offs for drug advertising expenses.

Zooming out: Lawmakers have unsuccessfully attempted to enact similar pharma ad restrictions in both the House and Senate beginning in 2009, with multiple proposed laws as recently as December.

However, the latest push, which is led by a Republican for the first time, follows Trump administration enthusiasm under HHS Secretary Robert F. Kennedy Jr. to ban pharma direct-to-consumer advertising.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account